TCRT - Alaunos Therapeutics Inc
1.48
-0.020 -1.351%
Share volume: 11,904
Last Updated: 03-13-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$1.50
-0.02
-0.01%
Summary score
16%
Profitability
0%
Dept financing
32%
Liquidity
50%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-29.8%
Return on sales
-174200%
Return on invested capital
0%
Total debt ratio
21.9%
Debt ratio change over timeo
0%
Current Ratio
4.58%
Quick Ratio
0%
Cash Position Ratio
2.69%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-29.8%
Return on sales
-174200%
Return on invested capital
0%
Total debt ratio
21.9%
Debt ratio change over timeo
0%
Current Ratio
4.58%
Quick Ratio
0%
Cash Position Ratio
2.69%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-27.86%
Return on sales
-174200%
Return on invested capital
0%
Total debt ratio
20.54%
Debt ratio change over time
0%
Current Ratio
4.87%
Quick Ratio
0%
Cash Position Ratio
3.34%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TCRT | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 18.83% | 17.34% | 0% |
| Return on assets | -29.8% | 4.14% | 8.21% | 0% |
| Return on sales | -174200% | 27.93% | 41.18% | 0% |
| Return on invested capital | 0% | 9.79% | -219.55% | 0% |
| Profitability | 0% | 80% | 73% | 0% |
| Total debt ratio | 21.9% | 82.52% | 55.88% | 0% |
| Debt ratio change over time | 0% | -13.08% | -0.73% | 0% |
| Dept financing | 32% | 25% | 17% | 0% |
| Current Ratio | 4.58% | 1.13% | 0% | 0% |
| Quick Ratio | 0% | 0.87% | 0% | 0% |
| Cash Position Ratio | 2.69% | 0.12% | 0% | 0% |
| Liquididy | 50% | 33% | 32% | 0% |
| Short-term ratios | TCRT | LLY | NVO | NONOF |
|---|---|---|---|---|
| Return on equity | 0% | 13.31% | 0% | 0% |
| Return on assets | -29.8% | 4.46% | 0% | 0% |
| Return on sales | -174200% | 29.96% | 0% | 0% |
| Return on invested capital | 0% | 10.68% | 0% | 0% |
| Profitability | 0% | 100% | 0% | 0% |
| Total debt ratio | 21.9% | 81.12% | 0% | 0% |
| Debt ratio change over time | 0% | -58.72% | 0% | 0% |
| Dept financing | 32% | 25% | 0% | 0% |
| Current Ratio | 4.58% | 1.13% | 0% | 0% |
| Quick Ratio | 0% | 0.87% | 0% | 0% |
| Cash Position Ratio | 2.69% | 0.12% | 0% | 0% |
| Liquididy | 50% | 32% | 0% | 0% |